Electromechanical mapping identifies improvement in function and retention of contractile reserve after revascularization in ischemic cardiomyopathy

Circulation

Volumn 110, Issue 16, 2004, Pages 2410-2416

  Samady, Habib ^b   Choi, C Joon ^a   Ragosta, Michael ^a   Powers, Eric R ^a   Beller, George A ^a   Kramer, Christopher M ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b SENTARA NORFOLK GENERAL HOSPITAL   (United States)

Author keywords

Cardiomyopathy; Infarction; Ischemia; Magnetic resonance imaging; Mapping

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CONVALESCENCE; DISEASE SEVERITY; DOBUTAMINE CARDIAC MAGNETIC RESONANCE IMAGING; ELECTRIC POTENTIAL; EXCITATION CONTRACTION COUPLING; FEMALE; FUNCTIONAL ASSESSMENT; HEART FUNCTION; HEART FUNCTION TEST; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE CONTRACTILE FORCE; HEART MUSCLE ISCHEMIA; HEART MUSCLE POTENTIAL; HEART MUSCLE REVASCULARIZATION; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REST; REVASCULARIZATION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADULT; AGED; CORONARY ARTERY BYPASS; DOBUTAMINE; ELECTROPHYSIOLOGY; FEMALE; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; POSTOPERATIVE PERIOD; RECOVERY OF FUNCTION; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 6444224407     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000145119.94542.AE     Document Type: Article

References (17)

1. Samady H, Elefteriades JA, Abbott BG, et al. Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome. Circulation. 1999;100:1298-1304.
2. Ben-Haim SA, Osadchy D, Schuster I, et al. Nonfluoroscopic, in vivo navigation and mapping technology. Nat Med. 1996;2:1393-1395.
3. Gepstein L, Hayam G, Ben-Haim SA. A novel method for nonfluoroscopic catheter-based electroanatomical mapping of the heart: in vitro and in vivo accuracy results. Circulation. 1997;95:1611-1622.
4. Kornowski R, Hong MK, Gepstein L, et al. Preliminary animal and clinical experiences using an electromechanical endocardial mapping procedure to distinguish infarcted from healthy myocardium. Circulation. 1998;98:1116-1124.
5. Kornowski R, Hong MK, Leon MB. Comparison between left ventricular electromechanical mapping and radionuclide perfusion imaging for detection of myocardial viability. Circulation. 1998;98:1837-1841.
6. Botker HE, Lassen JF, Hermansen F, et al. Electromechanical mapping for detection of myocardial viability in patients with ischemic cardiomyopathy. Circulation. 2001;103:1631-1637.
7. Koch KC, vom Dahl J, Wenderdel M, et al. Myocardial viability assessment by endocardial electroanatomic mapping: comparison with metabolic imaging and functional recovery after coronary revascularization. J Am Coll Cardiol. 2001;38:91-98.
8. Gyongyosi M, Sochor H, Khorsand A, et al. Online myocardial viability assessment in the catheterization laboratory via NOGA electroanatomic mapping: quantitative comparison with thallium-201 uptake. Circulation. 2001;104:1005-1011.
9. Fuchs S, Hendel RC, Baim DS, et al. Comparison of endocardial electromechanical mapping with radionuclide perfusion imaging to assess myocardial viability and severity of myocardial ischemia in angina pectoris. Am J Cardiol. 2001;87:874-880.
10. Samady H, Liu YH, Choi MJ, et al. Electromechanic mapping for detection of myocardial viability and ischemia in patients with severe ischemic cardiomyopathy. Am J Cardiol. 2003;91:807-811.
11. Perin EC, Guilherme VS, Sarmetno-Siete R, et al. Assessing myocardial viability and infarct transmurality with left ventricular electromechanical mapping in patients with stable coronary artery disease. Circulation. 2002;106:957-961.
12. Zerhouni EA, Parish DM, Rogers WJ, et al. Human heart: tagging with MR imaging: a new method for noninvasive assessment of myocardial motion. Radiology. 1988;169:59-63.
13. Geskin G, Kramer CM, Rogers WJ, et al. Quantitative assessment of myocardial viability post-infarction by dobutamine magnetic resonance tagging. Circulation. 1998;98:217-223.
14. Kramer CM, Rogers WJ, Theobald T, et al. Remote noninfarcted region dysfunction soon after first anterior myocardial infarction: a magnetic resonance tagging study. Circulation. 1996;94:660-666.
15. Power T, Kramer CM, Shaffer AL, et al. Breathhold dobutamine magnetic resonance tissue tagging: normal left ventricular response. Am J Cardiol. 1997;80:1203-1207.
16. Kim RJ, Wu E, Rafeal A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343:1445-1453.
17. Wellnhofer E, Olariu A, Klein C, et al. Magnetic resonance low-dose dobutamine test is superior to scar quantification for the prediction of functional recovery. Circulation. 2004;109:2172-2174.